FDA approves Vonjo (Pacritinib) for adult patients with a type of bone marrow cancer

Feb 28 (Reuters) - CTI BioPharma Corp (CTIC.O) said on Monday the U.S. Food and Drug Administration had approved its drug for treating adult patients with a type of bone marrow cancer who also have low blood platelet count.